Below are some of the unlisted options held by Nina (per annual report):
Nina is a very competent CEO/MD, if Phase3 trial is successful, she should be rewarded in some way imo even if the above options are fully expired/lapsed (looks like so. just don't understand why they initially put expiry date on exactly same time/date yet with different exercise prices hope it was a mistake and the expiry date with higher exe price is actually in a bit later years)..
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ, page-343
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
-0.010(2.20%) |
Mkt cap ! $247.9M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.8¢ | 43.8¢ | $701.3K | 1.564M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 111371 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 8072 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |